Polyphenol-rich sorghum brans alter colon microbiota and impact species diversity and species richness after multiple bouts of dextran sodium sulfate-induced colitis

FEMS Microbiology Ecology

Volumn 91, Issue 3, 2015, Pages

  Ritchie, Lauren E ^a   Sturino, Joseph M ^a   Carroll, Raymond J ^a   Rooney, Lloyd W ^a   Andrea Azcarate Peril, M ^b   Turner, Nancy D ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Chao; Inflammatory bowel disease; Shannon weaver; Short chain fatty acids

Indexed keywords

ABNORMALITY; ARTIFICIAL DIET; BACTERIUM; CARBOXYLIC ACID; CELLULOSE; CONCENTRATION (COMPOSITION); DICOTYLEDON; DIGESTIVE SYSTEM DISORDER; FATTY ACID; MICROBIOLOGY; RODENT; SODIUM; SORGHUM; SPECIES DIVERSITY; SPECIES RICHNESS; SULFATE; TANNIN;

ACTINOBACTERIA; BACTEROIDALES; BACTEROIDES; CLOSTRIDIALES; CLOSTRIDIUM; FIRMICUTES; LACTOBACILLALES; LACTOBACILLUS; RATTUS; RHUS;

BUTYRIC ACID DERIVATIVE; DEXTRAN SULFATE; POLYPHENOL; RNA 16S;

ACTINOBACTERIA; ADMINISTRATION AND DOSAGE; ANIMAL; CHEMISTRY; CLOSTRIDIUM; COLITIS; COLON; DIETARY FIBER; FOOD GRAIN; GENETICS; ISOLATION AND PURIFICATION; LACTOBACILLALES; LACTOBACILLUS; MALE; METABOLISM; MICROBIOLOGY; MICROFLORA; PATHOLOGY; RAT; SORGHUM; SPRAGUE DAWLEY RAT;

ACTINOBACTERIA; ANIMALS; BUTYRATES; CLOSTRIDIUM; COLITIS; COLON; DEXTRAN SULFATE; DIETARY FIBER; EDIBLE GRAIN; LACTOBACILLALES; LACTOBACILLUS; MALE; MICROBIOTA; POLYPHENOLS; RATS; RATS, SPRAGUE-DAWLEY; RNA, RIBOSOMAL, 16S; SORGHUM;

EID: 84942311009     PISSN: 01686496     EISSN: 15746941     Source Type: Journal    
DOI: 10.1093/femsec/fiv008     Document Type: Article

References (68)

1. Ahn YJ, Lee CO, Kweon JH, et al. Growth-inhibitory effects of Galla Rhois-derived tannins on intestinal bacteria. J Appl Microbiol 1998;84:439-43.
2. Andoh A, Imaeda H, Aomatsu T, et al. Comparison of the fecalmicrobiota profiles between ulcerative colitis and Crohn's disease using terminal restriction fragment length polymorphism analysis. J Gastroenterol 2011;46:479-86.
3. Biasi F, Astegiano M, Maina M, et al. Polyphenol supplementation as a complementary medicinal approach to treating inflammatory bowel disease. Curr Med Chem 2011;18:4851-65.
4. Bibiloni R, Mangold M, Madsen KL, et al. The bacteriology of biopsies differs between newly diagnosed, untreated, Crohn's disease and ulcerative colitis patients. J Med Microbiol 2006;55:1141-9.
5. Borges G, Roowi S, Rouanet JM, et al. The bioavailability of raspberry anthocyanins and ellagitannins in rats. Mol Nutr Food Res 2007;51:714-25.
6. Burdette A. Anti-inflammatory activity of select sorghum (Sorghum bicolor) brans. J Med Food 2010;13:879.
7. Caporaso JG, Kuczynski J, Stombaugh J, et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods 2010;7:335-6.
8. Chassard C, Gaillard-Martinie B, Bernalier-Donadille A. Interaction between H2-producing and non-H2-producing cellulolytic bacteria from the human colon. FEMS Microbiol Lett 2005;242:339-44.
9. Chung KT, Lu Z, Chou MW. Mechanism of inhibition of tannic acid and related compounds on the growth of intestinal bacteria. Food Chem Toxicol 1998;36:1053-60.
10. Croswell A. Prolonged impact of antibiotics on intestinal microbial ecology and susceptibility to enteric Salmonella infection. Infect Immun 2009;77:2741-53.
11. Crozier A, Del Rio D, Clifford MN. Bioavailability of dietary flavonoids and phenolic compounds. Mol Aspects Med 2010;31:446-67.
12. Cueva C, Sánchez-Patán F, Monagas M, et al. In vitro fermentation of grape seed flavan-3-ol fractions by human faecal microbiota:changes in microbial groups and phenolic metabolites. FEMS Microbiol Ecol 2012;83:792-805.
13. Davis LMG, Davis Is, MartAñez J, et al. Barcoded pyrosequencing reveals that consumption of galactooligosaccharides results in a highly specific bifidogenic response in humans. PLoS One 2011;6:e25200.
14. Devine AA, Gonzalez A, Speck KE, et al. Impact of ileocecal resection and concomitant antibiotics on the microbiome of the murine jejunum and colon. PLoS One 2013;8:e73140.
15. Dykes L, Rooney LW. Sorghum and millet phenols and antioxidants. J Cereal Sci 2006;44:236-51.
16. Dykes L, Rooney WL, Rooney LW. Evaluation of phenolics and antioxidant activity of black sorghum hybrids. J Cereal Sci 2013;58:278-83.
17. Edgar RC. Search and clustering orders ofmagnitude faster than BLAST. Bioinformatics 2010;26:2460-1.
18. Edwards U, Rogall T, Blocker H, et al. Isolation and direct complete nucleotide determination of entire genes. Characterization of a gene coding for 16S ribosomal RNA. Nucleic Acids Res 1989;17:7843-53.
19. Elson CO, Cong Y, McCracken VJ, et al. Experimental models of inflammatory bowel disease reveal innate, adaptive, and regulatory mechanisms of host dialogue with the microbiota. Immunol Rev 2005;206:260-76.
20. Fierer N, Hamady M, Lauber CL, et al. The influence of sex, handedness, and washing on the diversity of hand surface bacteria. P Natl Acad Sci USA 2008;105:17994-9.
21. Frank DN, St. Amand AL, Feldman RA, et al. Molecularphylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. P Natl Acad Sci USA 2007;104:13780-5.
22. Garcia Vilela E, De LourdesDe Abreu Ferrari M, Oswaldo Da Gama Torres H, et al. Influence of Saccharomyces boulardii on the intestinal permeability of patients with Crohn's disease in remission. Scand J Gastroentero 2008;43:842-8.
23. Gibson GR, Probert HM, Loo JV, et al. Dietary modulation of the human colonic microbiota: updating the concept of prebiotics. Nutr Res Rev 2004;17:259-75.
24. Hamady M, Lozupone C, Knight R. Fast UniFrac: facilitating highthroughput phylogenetic analyses of microbial communities including analysis of pyrosequencing and PhyloChip data. ISME J 2010;4:17-27.
25. Hanske L. Xanthohumol does not affect the composition of rat intestinal microbiota. Mol Nutr Food Res 2005;49:868.
26. Heimesaat MM, Fischer A, Siegmund B, et al. Shift towards proinflammatory intestinal bacteria aggravates acute murine colitis via Toll-like receptors 2 and 4. PLoS One 2007;2:e662.
27. Itzkowitz SH, Yio X. Inflammation and Cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am J Physiol-Gastr L 2004;287:G7-17.
28. Jia Q, Lupton JR, Smith R, et al. Reduced colitis-associated colon cancer in Fat-1 (n-3 fatty acid desaturase) transgenic mice. Cancer Res 2008;68:3985-91.
29. Jimenez-Ramsey LM, Rogler JC, Housley TL, et al. Absorption and distribution of 14C-labeled condensed tannins and related sorghum phenolics in chickens. J Agr Food Chem 1994;42:963-7.
30. Larrosa M, Luceri C, Vivoli E, et al. Polyphenol metabolites from colonic microbiota exert anti-inflammatory activity on different inflammation models. Mol Nutr Food Res 2009;53:1044-54.
31. Larrosa M, Yañéz-Gascón Ma J, Selma Ma V, et al. Effect of a low dose of dietary resveratrol on colon microbiota, inflammation and tissue damage in a DSS-induced colitis rat model. J Agr Food Chem 2009;57:2211-20.
32. Lee I-A, Bae E-A, Hyun Y-J, et al. Dextran sulfate sodium and 2,4,6-trinitrobenzene sulfonic acid induce lipid peroxidation by the proliferation of intestinal gram-negative bacteria in mice. J Inflamm 2010;7:7.
33. Ley RE, Hamady M, Lozupone C, et al. Evolution of mammals and their gut microbes. Science 2008;320:1647-51.
34. Ljungh A, Wadstrom T. Lactic acid bacteria as probiotics. Curr Issues Intest Microbiol 2006;7:73-90.
35. Loftus EV, Jr. Clinical epidemiology of inflammatory bowel disease:incidence, prevalence, and environmental influences. Gastroenterology 2004;126:1504-17.
36. Louis P, Flint HJ. Diversity, metabolism and microbial ecology of butyrate-producing bacteria fromthe human large intestine. FEMS Microbiol Lett 2009;294:1-8.
37. Louis P, Scott KP, Duncan SH, et al. Understanding the effects of diet on bacterial metabolism in the large intestine. J Appl Microbiol 2007;102:1197-208.
38. Lozupone C, Hamady M, Knight R. UniFrac-an online tool for comparing microbial community diversity in a phylogenetic context. BMC Bioinformatics 2006;7:371.
39. Manichanh C, Rigottier-Gois L, Bonnaud E, et al. Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut 2006;55:205-11.
40. Martin HM, Campbell BJ, Hart CA, et al. Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer. Gastroenterology 2004;127:80-93.
41. Menon R, Watson SE, Thomas LN, et al. Diet complexity and estrogen receptor β status affect the composition of themurine intestinal microbiota. Appl Environ Microb 2013;79:5763-73.
42. Nagalingam NA, Kao JY, Young VB. Microbial ecology of the murine gut associated with the development of dextran sodium sulfate-induced colitis. Inflamm Bowel Dis 2011;17:917-26.
43. Nagalingam NA, Lynch SV. Role of the microbiota in inflammatory bowel diseases. Inflamm Bowel Dis 2012;18:968-84.
44. Noor S, Ridgway K, Scovell L, et al. Ulcerative colitis and irritable bowel patients exhibit distinct abnormalities of the gut microbiota. BMC Gastroenterol 2010;10:134.
45. Okubo T. In vivo effects of tea polyphenol intake on human intestinal microflora and metabolism. Biosci Biotech Bioch 1992;56:588.
46. Onderdonk AB, Richardson JA, Hammer RE, et al. Correlation of cecal microflora of HLA-B27 transgenic rats with inflammatory bowel disease. Infect Immun 1998;66:6022-3.
47. Ott SJ, Musfeldt M, Wenderoth DF, et al. Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut 2004;53:685-93.
48. Possemiers S, Bolca S, Verstraete W, et al. The intestinal microbiome:a separate organ inside the body with the metabolic potential to influence the bioactivity of botanicals. Fitoterapia 2011;82:53-66.
49. Rajilíc-Stojanovíc M, Biagi E, Heilig HGHJ, et al. Global and deep molecular analysis of microbiota signatures in fecal samples frompatients with irritable bowel syndrome. Gastroenterology 2011;141:1792-801.
50. Rajilíc-Stojanovíc M, Smidt H, De Vos WM. Diversity of the human gastrointestinal tract microbiota revisited. Environ Microbiol 2007;9:2125-36.
51. Rastall RA, Gibson GR, Gill HS, et al. Modulation of the microbial ecology of the human colon by probiotics, prebiotics and synbiotics to enhance human health: an overview of enabling science and potential applications. FEMS Microbiol Ecol 2005;52:145-52.
52. Rastmanesh R. High polyphenol, low probiotic diet for weight loss because of intestinal microbiota interaction. Chem Biol Interact 2011;189:1-8.
53. Ree T. Tannins: classification and definition. Nat Prod Rep 2001;18:641-9.
54. Reeder J, Knight R. Rapidly denoising pyrosequencing amplicon reads by exploiting rank-abundance distributions. Nat Methods 2010;7:668-9.
55. Ritchie LE, Burke KF, Garcia-Mazcorro JF, et al. Characterization of fecal microbiota in cats using universal 16S rRNA gene and group-specific primers for Lactobacillus and Bifidobacterium spp. Vet Microbiol 2010;144:140-6.
56. Sakakibara H, Ogawa T, Koyanagi A, et al. Distribution and excretion of bilberry anthocyanins in mice. J Agr Food Chem 2009;57:7681-6.
57. Sepehri S, Kotlowski R, Bernstein CN, et al. Microbial diversity of inflamed and noninflamed gut biopsy tissues in inflammatory bowel disease. Inflamm Bowel Dis 2007;13:675-83.
58. Smith AH, Mackie RI. Effect of condensed tannins on bacterial diversity and metabolic activity in the rat gastrointestinal tract. Appl Environ Microb 2004;70:1104-15.
59. Sokol H, Seksik P, Rigottier-Gois L, et al. Specificities of the fecal microbiota in inflammatory bowel disease. Inflamm Bowel Dis 2006;12:106-11.
60. Swidsinski A, Weber J, Loening-Baucke V, et al. Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease. J Clin Microbiol 2005;43:3380-9.
61. Thibault R, Thibault P, De Coppet K, et al. Down-regulation of the monocarboxylate transporter 1 is involved in butyrate deficiency during intestinal inflammation. Gastroenterology 2007;133:1916-27.
62. Turner N, Taddeo SS, McDonough CM, et al. Polyphenol-rich sorghum brans promote fecalwater retention and alter short chain fatty acids in Sprague Dawley rats. Cereal Foods World 2010;55(4 Suppl.):A72-3.
63. van Duynhoven J, Vaughan EE, Jacobs DM, et al. Metabolic fate of polyphenols in the human superorganism. P Natl Acad Sci USA 2011;108:4531-8.
64. Vicky De P, Greet V, Paul JR, et al. T1795 Impaired butyrate oxidation in ulcerative colitis is due to decreased butyrate uptake and a defect in the oxidation pathway. Gastroenterology 2010;138:S-580.
65. Walker AW, Ince J, Duncan SH, et al. Dominant and dietresponsive groups of bacteria within the human colonic microbiota. ISME J 2010;5:220-30.
66. Wells JM, Rossi O, Meijerink M, et al. Epithelial crosstalk at the microbiota-mucosal interface. P Natl Acad Sci USA 2010;108(Suppl. 1):4607-14.
67. Wiegel J, Kuk S-U, Kohring GW. Clostridium thermobutyricum sp. nov., a moderate thermophile isolated from a cellulolytic culture, that produces butyrate as the major product. Int J Syst Bacteriol 1989;39:199-204.
68. Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007;448:427-34.